VIM and cancer: Furthermore, vimentin staining of the tumors that never reached the doubling endpoint in the combination group revealed the presence of remaining cancer cells (Figure S3), indicating that longer treatments times would be required to potentially eradicate orthotopic MDA-MB-231 tumors in mice.